1 |
Timmerman D, Planchamp F, Bourne T, et al. ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors[J]. Int J Gynecol Cancer, 2021, 31(7): 961-982.
|
2 |
Torre LA, Trabert B, Desantis CE, et al. Ovarian cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(4): 284-296.
|
3 |
Ledermann JA, Raja FA, Fotopoulou C, et al. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2018, 29(Suppl4): iv259.
|
4 |
Pavlik EJ, Depriest PD, Gallion HH, et al. Ovarian volume related to age[J]. Gynecologic Oncology, 2000, 77(3): 410-412.
|
5 |
Rosen DG, Wang L, Atkinson JN, et al. Potential markers that complement expression of CA125 in epithelial ovarian cancer[J]. Gynecol Oncol, 2005, 99(2): 267-277.
|
6 |
Timmerman D, Valentin L, Bourne TH, et al. Terms, definitions and measurements to describe the ultrasonographic features of adnexal tumors:a consensus opinion from the international ovarian tumor analysis(IOTA) group[J]. Ultrasound Obstet Gynecol, 2000, 16(5): 500-505.
|
7 |
Amor F, Alcázar JL, Vaccaro H, et al. GI-RADS reporting system for ultrasound evaluation of adnexal masses in clinical practice :a prospective multicenter study[J]. Ultrasound Pbstet Gynecol, 2011, 38(4): 450-455.
|
8 |
Andreotti RF, Timmerman D, Strachowski LM. O-RADS US risk stratification and management system:a consensus guideline from the ACR ovarian-adnexal reporting and data system committee[J]. Radiology, 2020, 294(1): 168-185.
|
9 |
Andreotti RF, Timmermsn D, Benacerraf BR, et al. Ovarian-adnexal reporting lexicon for ultrasound: a white paper of the ACR ovarian adnexal reporting and data system committee[J]. J Am Coll Radiol, 2018, 15(10): 1415-1429.
|
10 |
Alcázar JL, Rodriguez D. Three-dimensional power Doppler vascular sonographic sampling for predicting ovarian cancer in cystic-solid and solid vascularized masses[J]. J Ultrasound Med, 2009, 28(3): 275-281.
|
11 |
Berek JS, Kehoe ST, Kumar L, et al. Cancer of the ovary.fallopian tube,and peritoneum[J]. Int J Gynecol Obstet, 2018, 143(Suppl2): 59-78.
|
12 |
Giampaolino P, Della Cortel L, Foreste V, et al. Unraveling a difficult diagnosis:the tricks for early recognition of ovarian cancer[J]. Minerva Med, 2019, 110(4): 279-291.
|
13 |
Wang YC,Tian JY, Han YY, et al. Evaluation of the potential of ultrasound-mediated drug delivery for the treatment of ovarian canaer through preclinical studies[J]. Front Oncol, 2022, 5(12): 978603.
|
14 |
赵斌, 南媛, 郝妮娜, 等. 1999—2018年间女性恶性肿瘤住院患者病例资料回顾性研究[J]. 中国生育健康杂志, 2020, 31(4): 353-357.
|
15 |
Stewart C, Ralyea C, Lockwood S. Ovarian cancer: an integrated review[J]. Semin Oncol Nurs, 2019, 35(2): 151-156.
|
16 |
Hiett AK, Sonek JD, Guy M, et al. Performance of IOTA Simple Rules risk assessment ADNEX model and O-RADS in differenting between benign and malignant adnexal lesions in North American women[J]. Ultrasound Obstet Gynecol, 2022, 59(5): 668-676.
|
17 |
许彩, 周苑, 赵胜, 崔新伍. 卵巢-附件报告与数据系统在超声诊断卵巢-附件肿块良恶性中的价值[J/OL]. 中华医学超声杂志(电子版), 2023, 20(1): 51-56.
|